John Arthur
Concepts (334)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 23 | 2019 | 328 | 3.730 |
Why?
| Acute Kidney Injury | 14 | 2023 | 283 | 3.240 |
Why?
| Renal Insufficiency, Chronic | 10 | 2024 | 168 | 2.690 |
Why?
| Glomerulonephritis, Membranous | 6 | 2023 | 27 | 1.750 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 18 | 2010 | 37 | 1.460 |
Why?
| Kidney | 10 | 2020 | 665 | 1.410 |
Why?
| Lupus Nephritis | 5 | 2023 | 17 | 1.090 |
Why?
| Proteinuria | 5 | 2007 | 39 | 1.050 |
Why?
| Kidney Diseases | 3 | 2019 | 214 | 0.900 |
Why?
| Autoantibodies | 3 | 2023 | 116 | 0.850 |
Why?
| Glomerulonephritis | 2 | 2019 | 13 | 0.780 |
Why?
| Proteins | 5 | 2010 | 341 | 0.750 |
Why?
| Kidney Glomerulus | 8 | 2019 | 39 | 0.710 |
Why?
| Proteome | 3 | 2019 | 173 | 0.680 |
Why?
| Uremia | 1 | 2019 | 12 | 0.670 |
Why?
| Ruminococcus | 1 | 2019 | 8 | 0.670 |
Why?
| Urea | 1 | 2019 | 77 | 0.660 |
Why?
| Cecum | 1 | 2019 | 63 | 0.650 |
Why?
| Starch | 1 | 2019 | 28 | 0.650 |
Why?
| Glomerular Filtration Rate | 3 | 2015 | 111 | 0.630 |
Why?
| Predictive Value of Tests | 11 | 2018 | 904 | 0.630 |
Why?
| Bacteria | 2 | 2020 | 223 | 0.620 |
Why?
| Hypertension | 4 | 2020 | 532 | 0.610 |
Why?
| Diabetic Nephropathies | 4 | 2015 | 61 | 0.600 |
Why?
| Intestines | 1 | 2019 | 176 | 0.600 |
Why?
| Bacterial Proteins | 2 | 2019 | 373 | 0.580 |
Why?
| Humans | 52 | 2024 | 49827 | 0.570 |
Why?
| Renin-Angiotensin System | 6 | 2021 | 59 | 0.550 |
Why?
| Prognosis | 8 | 2023 | 1952 | 0.540 |
Why?
| Glomerulosclerosis, Focal Segmental | 3 | 2014 | 13 | 0.500 |
Why?
| Interleukin-18 | 2 | 2015 | 27 | 0.480 |
Why?
| Disease Progression | 7 | 2020 | 822 | 0.470 |
Why?
| Animals | 28 | 2020 | 13150 | 0.470 |
Why?
| Renal Replacement Therapy | 2 | 2023 | 29 | 0.470 |
Why?
| Hyponatremia | 2 | 2011 | 11 | 0.450 |
Why?
| Benzazepines | 2 | 2011 | 19 | 0.450 |
Why?
| Membrane Glycoproteins | 2 | 2015 | 240 | 0.440 |
Why?
| Rats | 13 | 2019 | 3300 | 0.420 |
Why?
| Male | 32 | 2023 | 25093 | 0.420 |
Why?
| Podocytes | 4 | 2014 | 19 | 0.410 |
Why?
| Diabetes Mellitus | 1 | 2015 | 283 | 0.400 |
Why?
| Angiotensin II | 4 | 2021 | 157 | 0.400 |
Why?
| Cardiac Surgical Procedures | 2 | 2013 | 298 | 0.380 |
Why?
| Nephrology | 2 | 2022 | 11 | 0.360 |
Why?
| Azotemia | 1 | 2010 | 2 | 0.360 |
Why?
| Kidney Tubular Necrosis, Acute | 1 | 2010 | 8 | 0.360 |
Why?
| Inappropriate ADH Syndrome | 1 | 2010 | 2 | 0.360 |
Why?
| Thrombosis | 2 | 2023 | 249 | 0.350 |
Why?
| Angiotensinogen | 3 | 2013 | 12 | 0.330 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 10 | 2013 | 63 | 0.330 |
Why?
| Creatinine | 6 | 2018 | 140 | 0.330 |
Why?
| Angiotensin I | 4 | 2014 | 14 | 0.330 |
Why?
| Sodium | 3 | 2015 | 92 | 0.330 |
Why?
| Peptidyl-Dipeptidase A | 3 | 2021 | 27 | 0.320 |
Why?
| Female | 21 | 2023 | 26329 | 0.310 |
Why?
| Reproducibility of Results | 5 | 2010 | 1188 | 0.290 |
Why?
| Rats, Sprague-Dawley | 7 | 2019 | 1595 | 0.290 |
Why?
| Kidney Cortex | 2 | 2006 | 22 | 0.290 |
Why?
| Middle Aged | 15 | 2023 | 11997 | 0.280 |
Why?
| Mass Spectrometry | 8 | 2023 | 306 | 0.280 |
Why?
| Myocardium | 2 | 2006 | 429 | 0.280 |
Why?
| Urine | 2 | 2003 | 23 | 0.270 |
Why?
| Sea Lions | 2 | 2015 | 2 | 0.260 |
Why?
| Immunoglobulin G | 3 | 2023 | 186 | 0.260 |
Why?
| Kainic Acid | 2 | 2015 | 29 | 0.260 |
Why?
| Aged | 12 | 2020 | 9272 | 0.250 |
Why?
| Severity of Illness Index | 5 | 2015 | 942 | 0.250 |
Why?
| Aged, 80 and over | 6 | 2015 | 3125 | 0.240 |
Why?
| Furosemide | 2 | 2015 | 10 | 0.240 |
Why?
| Diuretics | 2 | 2015 | 23 | 0.240 |
Why?
| Peptide Fragments | 4 | 2014 | 216 | 0.230 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2004 | 349 | 0.220 |
Why?
| Kidney Medulla | 1 | 2002 | 16 | 0.220 |
Why?
| Glutamyl Aminopeptidase | 4 | 2017 | 4 | 0.210 |
Why?
| Models, Biological | 3 | 2016 | 728 | 0.200 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2022 | 19 | 0.200 |
Why?
| Urinalysis | 2 | 2013 | 34 | 0.200 |
Why?
| Antibodies, Neutralizing | 1 | 2022 | 64 | 0.200 |
Why?
| Medicine | 1 | 2022 | 56 | 0.200 |
Why?
| Receptor, Angiotensin, Type 1 | 1 | 2021 | 57 | 0.190 |
Why?
| Blood Platelets | 1 | 2023 | 245 | 0.190 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2020 | 70 | 0.180 |
Why?
| Adult | 10 | 2019 | 13160 | 0.180 |
Why?
| Vaccination | 1 | 2022 | 268 | 0.170 |
Why?
| Students, Medical | 1 | 2022 | 159 | 0.170 |
Why?
| Clinical Competence | 2 | 2024 | 398 | 0.170 |
Why?
| Kidney Tubules, Collecting | 2 | 2011 | 9 | 0.170 |
Why?
| Sphingolipids | 1 | 2019 | 15 | 0.170 |
Why?
| Permeability | 1 | 2019 | 68 | 0.170 |
Why?
| Internship and Residency | 1 | 2024 | 446 | 0.160 |
Why?
| Membrane Proteins | 2 | 2023 | 342 | 0.150 |
Why?
| Algorithms | 3 | 2016 | 616 | 0.150 |
Why?
| Host-Pathogen Interactions | 1 | 2019 | 129 | 0.150 |
Why?
| Intestinal Mucosa | 1 | 2019 | 225 | 0.150 |
Why?
| Vancomycin | 1 | 2018 | 82 | 0.150 |
Why?
| Mesangial Cells | 2 | 2015 | 4 | 0.150 |
Why?
| User-Computer Interface | 3 | 2008 | 82 | 0.150 |
Why?
| Cryopreservation | 1 | 2017 | 30 | 0.150 |
Why?
| Receptors, Virus | 2 | 2015 | 25 | 0.150 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 245 | 0.150 |
Why?
| Mitochondrial Proteins | 1 | 2017 | 90 | 0.140 |
Why?
| Chromatography, Liquid | 3 | 2013 | 232 | 0.140 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 197 | 0.140 |
Why?
| Area Under Curve | 2 | 2013 | 181 | 0.140 |
Why?
| Database Management Systems | 2 | 2008 | 28 | 0.140 |
Why?
| Heart Ventricles | 2 | 2010 | 248 | 0.140 |
Why?
| ROC Curve | 2 | 2013 | 232 | 0.130 |
Why?
| Blood Urea Nitrogen | 2 | 2020 | 41 | 0.130 |
Why?
| South Carolina | 1 | 2015 | 23 | 0.130 |
Why?
| Renin | 2 | 2013 | 14 | 0.130 |
Why?
| Kidney Function Tests | 1 | 2015 | 49 | 0.130 |
Why?
| Glycosphingolipids | 1 | 2015 | 3 | 0.130 |
Why?
| Kidney Transplantation | 1 | 2017 | 175 | 0.130 |
Why?
| Neuromuscular Depolarizing Agents | 1 | 2015 | 3 | 0.130 |
Why?
| Dietary Supplements | 1 | 2019 | 441 | 0.130 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2015 | 4 | 0.130 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2015 | 129 | 0.120 |
Why?
| Peptide Mapping | 3 | 2003 | 22 | 0.120 |
Why?
| Apolipoproteins E | 1 | 2015 | 56 | 0.120 |
Why?
| Regression Analysis | 1 | 2015 | 395 | 0.120 |
Why?
| Neurodegenerative Diseases | 1 | 2015 | 76 | 0.120 |
Why?
| Risk Factors | 4 | 2021 | 3619 | 0.120 |
Why?
| Mice | 8 | 2020 | 5720 | 0.120 |
Why?
| Platelet Count | 2 | 2024 | 72 | 0.110 |
Why?
| Haptoglobins | 1 | 2013 | 4 | 0.110 |
Why?
| Albuminuria | 3 | 2022 | 47 | 0.110 |
Why?
| Thioredoxins | 1 | 2013 | 24 | 0.110 |
Why?
| Amino Acid Sequence | 3 | 2003 | 587 | 0.110 |
Why?
| Angiotensins | 1 | 2013 | 12 | 0.110 |
Why?
| Exercise Test | 1 | 2013 | 121 | 0.110 |
Why?
| Molecular Sequence Data | 3 | 2003 | 797 | 0.110 |
Why?
| Infusions, Intravenous | 2 | 2011 | 207 | 0.110 |
Why?
| Radiation-Protective Agents | 1 | 2013 | 74 | 0.110 |
Why?
| Suramin | 1 | 2012 | 12 | 0.110 |
Why?
| Metabolic Networks and Pathways | 1 | 2013 | 89 | 0.100 |
Why?
| Time Factors | 3 | 2013 | 2912 | 0.100 |
Why?
| Anti-Bacterial Agents | 1 | 2018 | 743 | 0.100 |
Why?
| Blotting, Western | 3 | 2017 | 602 | 0.100 |
Why?
| Receptors, Phospholipase A2 | 2 | 2023 | 14 | 0.100 |
Why?
| Kidney Tubules, Proximal | 2 | 2015 | 62 | 0.100 |
Why?
| Intensive Care Units | 1 | 2013 | 210 | 0.100 |
Why?
| Mitochondria | 1 | 2015 | 397 | 0.100 |
Why?
| Bone Marrow | 1 | 2013 | 362 | 0.100 |
Why?
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 1 | 0.100 |
Why?
| Chemistry, Pharmaceutical | 1 | 2011 | 32 | 0.100 |
Why?
| Platelet Aggregation Inhibitors | 2 | 2023 | 174 | 0.100 |
Why?
| Retrospective Studies | 4 | 2015 | 6117 | 0.090 |
Why?
| Neprilysin | 4 | 2013 | 14 | 0.090 |
Why?
| Mechanotransduction, Cellular | 1 | 2011 | 36 | 0.090 |
Why?
| Nephrosis, Lipoid | 1 | 2010 | 5 | 0.090 |
Why?
| Retinol-Binding Proteins, Plasma | 1 | 2010 | 3 | 0.090 |
Why?
| Neoplasms | 1 | 2020 | 1233 | 0.090 |
Why?
| Endothelial Cells | 1 | 2012 | 269 | 0.090 |
Why?
| Serum Albumin | 1 | 2010 | 58 | 0.090 |
Why?
| Epithelial Cells | 1 | 2011 | 209 | 0.080 |
Why?
| Burkholderia cepacia complex | 1 | 2008 | 1 | 0.080 |
Why?
| Nickel | 1 | 2008 | 10 | 0.080 |
Why?
| Tropomyosin | 1 | 2008 | 5 | 0.080 |
Why?
| Vimentin | 1 | 2008 | 32 | 0.080 |
Why?
| Lamin Type A | 1 | 2008 | 7 | 0.080 |
Why?
| Risk Assessment | 1 | 2013 | 1262 | 0.080 |
Why?
| Proto-Oncogene Proteins | 2 | 2015 | 149 | 0.080 |
Why?
| Inflammation | 2 | 2023 | 604 | 0.080 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 553 | 0.080 |
Why?
| Information Storage and Retrieval | 2 | 2008 | 61 | 0.080 |
Why?
| Cell Line | 4 | 2015 | 1002 | 0.080 |
Why?
| Protein Array Analysis | 2 | 2008 | 23 | 0.080 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2008 | 188 | 0.070 |
Why?
| Models, Theoretical | 2 | 2005 | 174 | 0.070 |
Why?
| Nephrolithiasis | 1 | 2006 | 2 | 0.070 |
Why?
| Loop of Henle | 1 | 2006 | 8 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2013 | 467 | 0.070 |
Why?
| Kidney Tubules, Distal | 1 | 2006 | 14 | 0.070 |
Why?
| Diagnosis, Differential | 1 | 2010 | 1036 | 0.070 |
Why?
| Cluster Analysis | 1 | 2007 | 235 | 0.070 |
Why?
| Internet | 2 | 2008 | 261 | 0.070 |
Why?
| Diagnostic Techniques, Urological | 1 | 2005 | 1 | 0.070 |
Why?
| United States | 2 | 2013 | 4838 | 0.070 |
Why?
| Treatment Outcome | 4 | 2023 | 5138 | 0.070 |
Why?
| Hospitalization | 1 | 2010 | 653 | 0.060 |
Why?
| Chick Embryo | 1 | 2005 | 83 | 0.060 |
Why?
| Renal Dialysis | 1 | 2006 | 169 | 0.060 |
Why?
| Dialysis Solutions | 1 | 2004 | 3 | 0.060 |
Why?
| Kidney Neoplasms | 1 | 2006 | 178 | 0.060 |
Why?
| Databases, Protein | 1 | 2005 | 29 | 0.060 |
Why?
| Hemofiltration | 1 | 2004 | 7 | 0.060 |
Why?
| Protein Biosynthesis | 1 | 2006 | 253 | 0.060 |
Why?
| Feedback | 1 | 2024 | 53 | 0.060 |
Why?
| Accreditation | 1 | 2024 | 61 | 0.060 |
Why?
| Terminology as Topic | 1 | 2004 | 63 | 0.060 |
Why?
| Antigen-Antibody Complex | 1 | 2023 | 35 | 0.050 |
Why?
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 5 | 0.050 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2002 | 16 | 0.050 |
Why?
| Antibodies | 1 | 2003 | 155 | 0.050 |
Why?
| Platelet Aggregation | 1 | 2023 | 71 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2013 | 282 | 0.050 |
Why?
| Adenosine | 1 | 2023 | 69 | 0.050 |
Why?
| Biopsy | 2 | 2018 | 582 | 0.050 |
Why?
| Kallikreins | 1 | 2002 | 18 | 0.050 |
Why?
| Ticlopidine | 1 | 2023 | 55 | 0.050 |
Why?
| Actins | 1 | 2003 | 118 | 0.050 |
Why?
| Apolipoproteins | 1 | 2021 | 11 | 0.050 |
Why?
| Education, Medical, Graduate | 1 | 2024 | 208 | 0.050 |
Why?
| Cohort Studies | 2 | 2018 | 1422 | 0.050 |
Why?
| Glomerular Basement Membrane | 1 | 2021 | 10 | 0.050 |
Why?
| Protein Processing, Post-Translational | 1 | 2003 | 171 | 0.050 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2021 | 25 | 0.050 |
Why?
| Mice, Knockout | 2 | 2017 | 841 | 0.050 |
Why?
| Career Choice | 1 | 2022 | 111 | 0.050 |
Why?
| Proteoglycans | 1 | 2021 | 80 | 0.050 |
Why?
| Neural Cell Adhesion Molecules | 1 | 2020 | 9 | 0.050 |
Why?
| Thrombospondins | 1 | 2020 | 8 | 0.050 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2022 | 388 | 0.050 |
Why?
| Disease Models, Animal | 2 | 2020 | 1451 | 0.050 |
Why?
| Calcium-Binding Proteins | 1 | 2020 | 54 | 0.050 |
Why?
| Logistic Models | 2 | 2013 | 891 | 0.050 |
Why?
| Genotype | 1 | 2021 | 538 | 0.050 |
Why?
| Autoantigens | 1 | 2020 | 58 | 0.050 |
Why?
| Young Adult | 3 | 2019 | 3936 | 0.050 |
Why?
| Case-Control Studies | 1 | 2023 | 1128 | 0.040 |
Why?
| Cytokines | 1 | 2022 | 612 | 0.040 |
Why?
| Cell Proliferation | 2 | 2015 | 1007 | 0.040 |
Why?
| Glycosylation | 1 | 2019 | 100 | 0.040 |
Why?
| Mice, Inbred C57BL | 2 | 2015 | 1806 | 0.040 |
Why?
| Colorimetry | 1 | 2018 | 12 | 0.040 |
Why?
| Cadaver | 1 | 2018 | 97 | 0.040 |
Why?
| Manikins | 1 | 2018 | 35 | 0.040 |
Why?
| Rats, Inbred Lew | 1 | 2017 | 69 | 0.040 |
Why?
| Self Efficacy | 1 | 2018 | 128 | 0.040 |
Why?
| Ultrasonography, Interventional | 1 | 2018 | 135 | 0.040 |
Why?
| Fellowships and Scholarships | 1 | 2018 | 111 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2017 | 89 | 0.040 |
Why?
| Cells, Cultured | 2 | 2012 | 1571 | 0.030 |
Why?
| Antibody Specificity | 1 | 2015 | 36 | 0.030 |
Why?
| Cross Reactions | 1 | 2015 | 41 | 0.030 |
Why?
| Lactosylceramides | 1 | 2015 | 2 | 0.030 |
Why?
| Oncogene Protein v-akt | 1 | 2015 | 10 | 0.030 |
Why?
| Information Dissemination | 2 | 2008 | 80 | 0.030 |
Why?
| Albumins | 1 | 2015 | 32 | 0.030 |
Why?
| Smad3 Protein | 1 | 2015 | 9 | 0.030 |
Why?
| Uromodulin | 1 | 2015 | 4 | 0.030 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2015 | 12 | 0.030 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 1 | 2015 | 29 | 0.030 |
Why?
| Lipocalins | 1 | 2015 | 13 | 0.030 |
Why?
| Child | 2 | 2022 | 6824 | 0.030 |
Why?
| Eosinophils | 1 | 2015 | 38 | 0.030 |
Why?
| Acute-Phase Proteins | 1 | 2015 | 24 | 0.030 |
Why?
| Radioligand Assay | 1 | 2014 | 46 | 0.030 |
Why?
| Feasibility Studies | 1 | 2016 | 374 | 0.030 |
Why?
| Neurotoxicity Syndromes | 1 | 2015 | 46 | 0.030 |
Why?
| Injections, Intravenous | 1 | 2014 | 140 | 0.030 |
Why?
| Treatment Failure | 1 | 2014 | 113 | 0.030 |
Why?
| Nephrectomy | 1 | 2014 | 83 | 0.030 |
Why?
| HEK293 Cells | 1 | 2014 | 222 | 0.030 |
Why?
| Antigens, CD | 1 | 2015 | 215 | 0.030 |
Why?
| Adolescent | 2 | 2019 | 6340 | 0.030 |
Why?
| Mice, Congenic | 1 | 2013 | 7 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2014 | 376 | 0.030 |
Why?
| Colony-Forming Units Assay | 1 | 2013 | 23 | 0.030 |
Why?
| Extracellular Fluid | 1 | 2013 | 15 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2013 | 9 | 0.030 |
Why?
| Benzylamines | 1 | 2013 | 15 | 0.030 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 488 | 0.030 |
Why?
| Heterocyclic Compounds | 1 | 2013 | 28 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2013 | 26 | 0.030 |
Why?
| Hematopoiesis | 1 | 2013 | 71 | 0.030 |
Why?
| Systems Biology | 1 | 2013 | 33 | 0.030 |
Why?
| Bone Marrow Cells | 1 | 2013 | 192 | 0.030 |
Why?
| Bayes Theorem | 1 | 2013 | 108 | 0.030 |
Why?
| Carboxypeptidases | 1 | 2012 | 4 | 0.030 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 63 | 0.030 |
Why?
| Transforming Growth Factor beta1 | 1 | 2012 | 59 | 0.030 |
Why?
| Kaplan-Meier Estimate | 1 | 2013 | 469 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2013 | 585 | 0.030 |
Why?
| Hematopoietic Stem Cells | 1 | 2013 | 184 | 0.020 |
Why?
| Risk | 1 | 2012 | 320 | 0.020 |
Why?
| Up-Regulation | 1 | 2013 | 450 | 0.020 |
Why?
| Random Allocation | 1 | 2012 | 280 | 0.020 |
Why?
| Computational Biology | 2 | 2004 | 214 | 0.020 |
Why?
| Odds Ratio | 1 | 2013 | 548 | 0.020 |
Why?
| Cilia | 1 | 2011 | 6 | 0.020 |
Why?
| Hospital Mortality | 1 | 2013 | 413 | 0.020 |
Why?
| Rotation | 1 | 2011 | 45 | 0.020 |
Why?
| Pilot Projects | 1 | 2013 | 699 | 0.020 |
Why?
| Blood Volume | 1 | 2011 | 68 | 0.020 |
Why?
| Protein Kinase C | 1 | 2011 | 71 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 83 | 0.020 |
Why?
| NF-kappa B | 1 | 2012 | 314 | 0.020 |
Why?
| Urinary Tract | 1 | 2010 | 27 | 0.020 |
Why?
| Tumor Suppressor Proteins | 1 | 2011 | 127 | 0.020 |
Why?
| Kidney Failure, Chronic | 1 | 2012 | 197 | 0.020 |
Why?
| Remission Induction | 1 | 2010 | 207 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1374 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 565 | 0.020 |
Why?
| Phosphorylation | 1 | 2011 | 536 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2011 | 555 | 0.020 |
Why?
| Protein Kinase Inhibitors | 1 | 2011 | 202 | 0.020 |
Why?
| Isoantibodies | 1 | 2008 | 27 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2008 | 174 | 0.020 |
Why?
| Protein Isoforms | 1 | 2008 | 119 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 651 | 0.020 |
Why?
| Signal Transduction | 1 | 2015 | 1617 | 0.020 |
Why?
| Rats, Wistar | 1 | 2008 | 223 | 0.020 |
Why?
| Hypermedia | 1 | 2008 | 1 | 0.020 |
Why?
| Knowledge Bases | 1 | 2008 | 9 | 0.020 |
Why?
| Cell Differentiation | 1 | 2011 | 653 | 0.020 |
Why?
| Prospective Studies | 1 | 2013 | 2344 | 0.020 |
Why?
| Reference Values | 1 | 2008 | 310 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2007 | 58 | 0.020 |
Why?
| Research Design | 1 | 2008 | 343 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2011 | 2179 | 0.020 |
Why?
| Programming Languages | 1 | 2004 | 6 | 0.010 |
Why?
| Computer Graphics | 1 | 2004 | 9 | 0.010 |
Why?
| Reference Standards | 1 | 2004 | 56 | 0.010 |
Why?
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2002 | 3 | 0.010 |
Why?
| Spodoptera | 1 | 2002 | 5 | 0.010 |
Why?
| Receptors, Formyl Peptide | 1 | 2002 | 4 | 0.010 |
Why?
| Receptors, Peptide | 1 | 2002 | 11 | 0.010 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2002 | 15 | 0.010 |
Why?
| Chemical Precipitation | 1 | 2002 | 3 | 0.010 |
Why?
| Tryptases | 1 | 2002 | 4 | 0.010 |
Why?
| Ultracentrifugation | 1 | 2002 | 9 | 0.010 |
Why?
| Acetone | 1 | 2002 | 7 | 0.010 |
Why?
| Isoproterenol | 1 | 2002 | 57 | 0.010 |
Why?
| Solvents | 1 | 2002 | 29 | 0.010 |
Why?
| Receptors, Immunologic | 1 | 2002 | 37 | 0.010 |
Why?
| Staining and Labeling | 1 | 2002 | 97 | 0.010 |
Why?
| Serine Endopeptidases | 1 | 2002 | 52 | 0.010 |
Why?
| Enzyme Activation | 1 | 2002 | 276 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 2002 | 182 | 0.010 |
Why?
| Child, Preschool | 1 | 2010 | 3853 | 0.010 |
Why?
| Software | 1 | 2004 | 273 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2005 | 1031 | 0.010 |
Why?
| Blood Pressure | 1 | 2002 | 514 | 0.010 |
Why?
|
|
Arthur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|